Literature DB >> 16378185

Common fragile genes and digestive tract cancers.

Tamotsu Kuroki1, Yoshitsugu Tajima, Jyunichiro Furui, Takashi Kanematsu.   

Abstract

FRA3B and FRA16D are the most sensitive common chromosomal fragile site loci in the human genome. Two tumor suppressor genes, the fragile histidine triad (FHIT) gene and the WW domain-containing oxidoreductase (WWOX), map to the common fragile sites, FRA3B and FRA16D, respectively. Interestingly, FHIT and WWOX have similarities: for example, they are both larger than 1 Mb and encompass fragile sites, they both show frequent allelic loss regions in various human cancers, they both span a region of homozygous deletion in multiple cancers, and they both frequently show aberrant transcripts. The development of human cancers, including digestive tract cancers, is strongly associated with exposure to environmental carcinogens. Common fragile sites are very sensitive to this type of exposure, and the resulting DNA damage leads to the inactivation of genes such as FHIT and WWOX. We present an overview of these two common fragile genes, namely FHIT/FRA3B and WWOX/FRA16D, in digestive tract cancers.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16378185     DOI: 10.1007/s00595-005-3094-4

Source DB:  PubMed          Journal:  Surg Today        ISSN: 0941-1291            Impact factor:   2.549


  42 in total

1.  Sequence conservation at human and mouse orthologous common fragile regions, FRA3B/FHIT and Fra14A2/Fhit.

Authors:  T Shiraishi; T Druck; K Mimori; J Flomenberg; L Berk; H Alder; W Miller; K Huebner; C M Croce
Journal:  Proc Natl Acad Sci U S A       Date:  2001-04-24       Impact factor: 11.205

2.  Chromosome 3p14 alterations in lung cancer: evidence that FHIT exon deletion is a target of tobacco carcinogens and asbestos.

Authors:  H H Nelson; J K Wiencke; L Gunn; J C Wain; D C Christiani; K T Kelsey
Journal:  Cancer Res       Date:  1998-05-01       Impact factor: 12.701

3.  Characterization of the human TESTIN gene localized in the FRA7G region at 7q31.2.

Authors:  C Tatarelli; A Linnenbach; K Mimori; C M Croce
Journal:  Genomics       Date:  2000-08-15       Impact factor: 5.736

4.  Altered expression of the fragile histidine triad gene in primary gastric adenocarcinomas.

Authors:  S H Lee; W H Kim; H K Kim; K M Woo; H S Nam; H S Kim; J G Kim; M H Cho
Journal:  Biochem Biophys Res Commun       Date:  2001-06-15       Impact factor: 3.575

5.  WWOX: a candidate tumor suppressor gene involved in multiple tumor types.

Authors:  A J Paige; K J Taylor; C Taylor; S G Hillier; S Farrington; D Scott; D J Porteous; J F Smyth; H Gabra; J E Watson
Journal:  Proc Natl Acad Sci U S A       Date:  2001-09-25       Impact factor: 11.205

6.  Absence of Msh2 protein expression is associated with alteration in the FHIT locus and Fhit protein expression in colorectal carcinoma.

Authors:  M Mori; K Mimori; T Masuda; K Yoshinaga; K Yamashita; A Matsuyama; H Inoue
Journal:  Cancer Res       Date:  2001-10-15       Impact factor: 12.701

7.  The tumor suppressor gene WWOX at FRA16D is involved in pancreatic carcinogenesis.

Authors:  Tamotsu Kuroki; Sai Yendamuri; Francesco Trapasso; Ayumi Matsuyama; Rami I Aqeilan; Hansjuerg Alder; Shashi Rattan; Rossano Cesari; Maria L Nolli; Noel N Williams; Masaki Mori; Takashi Kanematsu; Carlo M Croce
Journal:  Clin Cancer Res       Date:  2004-04-01       Impact factor: 12.531

8.  Alterations in the Fhit gene in pancreatic duct adenocarcinomas induced by N-nitrosobis(2-oxopropyl)amine in hamsters.

Authors:  Toshifumi Tsujiuchi; Yasutaka Sasaki; Tadahiko Kubozoe; Yoichi Konishi; Masahiro Tsutsumi
Journal:  Mol Carcinog       Date:  2003-02       Impact factor: 4.784

9.  Multiple occurrence of carcinoma in the upper aerodigestive tract associated with esophageal cancer: reference to smoking, drinking and family history.

Authors:  M Morita; H Kuwano; S Ohno; K Sugimachi; Y Seo; H Tomoda; M Furusawa; T Nakashima
Journal:  Int J Cancer       Date:  1994-07-15       Impact factor: 7.396

10.  Fragile histidine triad gene abnormalities in the pathogenesis of gallbladder carcinoma.

Authors:  Ignacio I Wistuba; Raheela Ashfaq; Anirban Maitra; Hector Alvarez; Erick Riquelme; Adi F Gazdar
Journal:  Am J Pathol       Date:  2002-06       Impact factor: 4.307

View more
  7 in total

1.  Deletion at fragile sites is a common and early event in Barrett's esophagus.

Authors:  Lisa A Lai; Rumen Kostadinov; Michael T Barrett; Daniel A Peiffer; Dimitry Pokholok; Robert Odze; Carissa A Sanchez; Carlo C Maley; Brian J Reid; Kevin L Gunderson; Peter S Rabinovitch
Journal:  Mol Cancer Res       Date:  2010-07-20       Impact factor: 5.852

2.  Association of the promoter methylation and protein expression of Fragile Histidine Triad (FHIT) gene with the progression of differentiated thyroid carcinoma.

Authors:  De-Tao Yin; Lin Wang; Jianrui Sun; Fengyan Yin; Qingtao Yan; Rulong Shen; Gang He; Jian-Xin Gao
Journal:  Int J Clin Exp Pathol       Date:  2010-05-25

3.  Low levels of WWOX protein immunoexpression correlate with tumour grade and a less favourable outcome in patients with urinary bladder tumours.

Authors:  D Ramos; M Abba; J A López-Guerrero; J Rubio; E Solsona; S Almenar; A Llombart-Bosch; C M Aldaz
Journal:  Histopathology       Date:  2008-04-29       Impact factor: 5.087

4.  The JNK inhibitor SP600129 enhances apoptosis of HCC cells induced by the tumor suppressor WWOX.

Authors:  Ileana Aderca; Catherine D Moser; Manivannan Veerasamy; Ahmad H Bani-Hani; Ruben Bonilla-Guerrero; Kadra Ahmed; Abdirashid Shire; Sophie C Cazanave; Damian P Montoya; Teresa A Mettler; Lawrence J Burgart; David M Nagorney; Stephen N Thibodeau; Julie M Cunningham; Jin-Ping Lai; Lewis R Roberts
Journal:  J Hepatol       Date:  2008-06-09       Impact factor: 25.083

Review 5.  Fhit tumor suppressor: guardian of the preneoplastic genome.

Authors:  Flavia Pichiorri; Tiziana Palumbo; Sung-Suk Suh; Hiroshi Okamura; Francesco Trapasso; Hideshi Ishii; Kay Huebner; Carlo M Croce
Journal:  Future Oncol       Date:  2008-12       Impact factor: 3.404

6.  Inhibition of colorectal cancer genomic copy number alterations and chromosomal fragile site tumor suppressor FHIT and WWOX deletions by DNA mismatch repair.

Authors:  Sohail Jahid; Jian Sun; Ozkan Gelincik; Pedro Blecua; Winfried Edelmann; Raju Kucherlapati; Kathy Zhou; Maria Jasin; Zeynep H Gümüş; Steven M Lipkin
Journal:  Oncotarget       Date:  2017-05-10

7.  Coordinate loss of fragile gene expression in pancreatobiliary cancers: correlations among markers and clinical features.

Authors:  Mark Bloomston; Jeffrey Kneile; Matthew Butterfield; Mary Dillhoff; Peter Muscarella; E Christopher Ellison; W Scott Melvin; Carlo M Croce; Flavia Pichiorri; Kay Huebner; Wendy L Frankel
Journal:  Ann Surg Oncol       Date:  2009-05-12       Impact factor: 5.344

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.